Urate oxidase

Revision as of 17:52, 13 April 2015 by Aparna Vuppala (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for Urate oxidase

Articles

Most recent articles on Urate oxidase

Most cited articles on Urate oxidase

Review articles on Urate oxidase

Articles on Urate oxidase in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Urate oxidase

Images of Urate oxidase

Photos of Urate oxidase

Podcasts & MP3s on Urate oxidase

Videos on Urate oxidase

Evidence Based Medicine

Cochrane Collaboration on Urate oxidase

Bandolier on Urate oxidase

TRIP on Urate oxidase

Clinical Trials

Ongoing Trials on Urate oxidase at Clinical Trials.gov

Trial results on Urate oxidase

Clinical Trials on Urate oxidase at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Urate oxidase

NICE Guidance on Urate oxidase

NHS PRODIGY Guidance

FDA on Urate oxidase

CDC on Urate oxidase

Books

Books on Urate oxidase

News

Urate oxidase in the news

Be alerted to news on Urate oxidase

News trends on Urate oxidase

Commentary

Blogs on Urate oxidase

Definitions

Definitions of Urate oxidase

Patient Resources / Community

Patient resources on Urate oxidase

Discussion groups on Urate oxidase

Patient Handouts on Urate oxidase

Directions to Hospitals Treating Urate oxidase

Risk calculators and risk factors for Urate oxidase

Healthcare Provider Resources

Symptoms of Urate oxidase

Causes & Risk Factors for Urate oxidase

Diagnostic studies for Urate oxidase

Treatment of Urate oxidase

Continuing Medical Education (CME)

CME Programs on Urate oxidase

International

Urate oxidase en Espanol

Urate oxidase en Francais

Business

Urate oxidase in the Marketplace

Patents on Urate oxidase

Experimental / Informatics

List of terms related to Urate oxidase

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The enzyme urate oxidase (UO), or uricase or factor-independent urate hydroxylase, absent in humans, catalyzes the oxidation of uric acid to 5-hydroxyisourate:[1]

Uric acid + O2 + H2O → 5-hydroxyisourate + H2O2allantoin + CO2
Uric acid
5-Hydroxyisourate
Allantoin

Structure

Urate oxidase is mainly localised in the liver, where it forms a large electron-dense paracrystalline core in many peroxisomes.[2] The enzyme exists as a tetramer of identical subunits, each containing a possible type 2 copper-binding site.[3]

Urate oxidase is a homotetrameric enzyme containing four identical active sites situated at the interfaces between its four subunits. UO from A. flavus is made up of 301 residues and has a molecular weight of 33438 dalton. It is unique among the oxidases in that it does not require a metal atom or an organic co-factor for catalysis. Sequence analysis of several organisms has determined that there are 24 amino acids which are conserved, and of these, 15 are involved with the active site.

factor-independent urate hydroxylase
Identifiers
EC number1.7.3.3
CAS number9002-12-4
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Uricase
Identifiers
SymbolUricase
PfamPF01014
InterProIPR002042
PROSITEPDOC00315
SCOP1uox
SUPERFAMILY1uox

Significance of absence in humans

Humans do have a gene for urate oxidase, but it is nonfunctional. Thus uric acid is the end product of catabolism of purines in humans. Excessive concentration of uric acid in the blood stream leads to gout.

Urate oxidase is found in nearly all organisms, from bacteria to mammals, and plays different metabolic roles, depending on its host organism. It was lost in early primate evolution,[3] and so is absent in humans and other higher apes.

It has been proposed that the loss of urate oxidase protein expression has been advantageous to hominids, since uric acid is a powerful antioxidant and scavenger of singlet oxygen and radicals.[4] Its presence provides the body with protection from oxidative damage, thus prolonging life and decreasing age-specific cancer rates. However, this is highly unlikely as proteins are capable of being activated only when concentrations exceed a certain amount. Adequate uric acid levels could still be maintained to protect the body while preventing evolutionarily disadvantageous conditions like gout.[dubious ]

Urate oxidase is formulated as a protein drug (rasburicase) for the treatment of acute hyperuricemia in patients receiving chemotherapy. A PEGylated form of urate oxidase is in clinical development for treatment of chronic hyperuricemia in patients with "treatment-failure gout".

In legumes

UO is also an essential enzyme in the ureide pathway, where nitrogen fixation occurs in the root nodules of legumes. The fixed nitrogen is converted to metabolites that are transported from the roots throughout the plant to provide the needed nitrogen for amino acid biosynthesis.

In legumes, 2 forms of uricase are found: in the roots, the tetrameric form; and, in the uninfected cells of root nodules, a monomeric form, which plays an important role in nitrogen-fixation.[5]

References

  1. Motojima K, Goto S, Kanaya S (1988). "Cloning and sequence analysis of cDNA for rat liver uricase". J. Biol. Chem. 263 (32): 16677–16681. PMID 3182808.
  2. Motojima K, Goto S (1990). "Organization of rat uricase chromosomal gene differs greatly from that of the corresponding plant gene". FEBS Lett. 264 (1): 156–158. doi:10.1016/0014-5793(90)80789-L. PMID 2338140.
  3. 3.0 3.1 Lee CC, Caskey CT, Wu XW, Muzny DM (1989). "Urate oxidase: primary structure and evolutionary implications". Proc. Natl. Acad. Sci. U.S.A. 86 (23): 9412–9416. doi:10.1073/pnas.86.23.9412. PMC 298506. PMID 2594778.
  4. Ames BN, Cathcart R, Schwiers E, Hochstein P (November 1981). "Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis". Proc. Natl. Acad. Sci. U.S.A. 78 (11): 6858–62. doi:10.1073/pnas.78.11.6858. PMC 349151. PMID 6947260.
  5. Nguyen T, Zelechowska M, Foster V, Bergmann H, Verma DPS (1985). "Primary structure of the soybean nodulin-35 gene encoding uricase II localized in the peroxisomes of uninfected cells of nodules". Proc. Natl. Acad. Sci. U.S.A. 82 (15): 5040–5044. doi:10.1073/pnas.82.15.5040. PMC 390494. PMID 16593585.
This article incorporates text from the public domain Pfam and InterPro: IPR002042